12/18
04:04 pm
gral
GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Medium
Report
GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
12/18
04:01 pm
gral
GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Medium
Report
GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference
12/4
09:12 am
gral
Function Health Collaborates With GRAIL to Offer Multi-Cancer Early Detection Test Nationwide [Yahoo! Finance]
Medium
Report
Function Health Collaborates With GRAIL to Offer Multi-Cancer Early Detection Test Nationwide [Yahoo! Finance]
12/3
04:01 pm
gral
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Medium
Report
GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
11/27
07:31 am
gral
Grail, Inc. (NASDAQ: GRAL) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $16.00 price target on the stock.
Low
Report
Grail, Inc. (NASDAQ: GRAL) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $16.00 price target on the stock.
11/19
04:05 pm
gral
GRAIL to Participate in Upcoming Investor Conferences
Medium
Report
GRAIL to Participate in Upcoming Investor Conferences
11/18
04:01 pm
gral
GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study
Medium
Report
GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study
11/15
08:17 am
gral
Grail, Inc. (NASDAQ: GRAL) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
Medium
Report
Grail, Inc. (NASDAQ: GRAL) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
11/12
04:06 pm
gral
GRAIL Reports Third Quarter 2024 Financial Results
Medium
Report
GRAIL Reports Third Quarter 2024 Financial Results
11/4
04:01 pm
gral
GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Low
Report
GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
10/29
04:01 pm
gral
GRAIL to Announce Third Quarter 2024 Financial Results
Medium
Report
GRAIL to Announce Third Quarter 2024 Financial Results
10/23
06:00 pm
gral
GRAIL Presents Initial Results From REFLECTION Real-World Evidence Study of Galleri® Multi-Cancer Early Detection (MCED) Test at the Early Detection of Cancer Conference
Medium
Report
GRAIL Presents Initial Results From REFLECTION Real-World Evidence Study of Galleri® Multi-Cancer Early Detection (MCED) Test at the Early Detection of Cancer Conference
10/21
04:01 pm
gral
GRAIL Appoints Sarah Krevans to Board of Directors
Low
Report
GRAIL Appoints Sarah Krevans to Board of Directors
10/17
08:14 am
gral
Grail, Inc. (NASDAQ: GRAL) is now covered by analysts at Guggenheim. They set a "neutral" rating on the stock.
Low
Report
Grail, Inc. (NASDAQ: GRAL) is now covered by analysts at Guggenheim. They set a "neutral" rating on the stock.